文献速递心血管介入DSA

心脏导管术患者辐射剂量的回顾性研究

Retrospective study of patients radiation dose during cardiac catheterization procedures.
PubMed 文献 · Br J Radiol · 2019-05-14

该研究回顾性分析本机构1000例患者六种心脏导管术的辐射剂量参数,报告各术式KAP与介入参考点空气比释动能的中位数及范围,并据此提出初始基准值,数据与已发表文献值相当。

要点

  • 六种术式中复杂PCI的KAP中位数最高(113.8 Gy-cm²),LH最低(44.4 Gy-cm²)。
  • 复杂PCI的Ka,r中位数最高(2260.2 mGy),CRT起搏器最低(463.8 mGy)。
  • 作者基于本中心现行实践提出各术式透视时间、KAP和Ka,r的初始基准值。

核心结论

  • 作者分析了本中心六种常用心脏导管术的患者辐射剂量,并基于现行实践提出透视时间、KAP和介入参考点空气比释动能的初始基准值。
  • 本中心数据与已发表文献中其他研究者为其机构建立基准剂量水平所报告的值相当。
  • 针对不同患者群体的术式特异性基准剂量数据可为监测实践提供动力,以促进心脏导管室患者辐射剂量优化。

研究设计与样本

  • 回顾性分析本机构1000例接受心脏导管术患者的剂量参数与技术参数。
  • 纳入术式包括左心导管(LH)、经皮冠状动脉介入治疗(PCI)、复杂PCI、LH联合复杂PCI、LH联合PCI以及心脏再同步治疗(CRT)起搏器植入。
  • 剂量数据取自医院RIS(Synapse)、Sensis/Syngo Dynamics及Siemens Sensis Stats Manager电子数据库,统计分析使用IBM SPSS Modeler v.18.1软件。

诊断标准与关键数值

  • LH的KAP中位数为44.4(4.1–203.2)Gy-cm²,Ka,r中位数为701.0(35.3–3794.0)mGy。
  • PCI的KAP中位数为80.2(18.9–208.5)Gy-cm²,Ka,r中位数为1384.7(291.7–4021.8)mGy。
  • LH联合复杂PCI的KAP中位数为83.7(48.0–246.1)Gy-cm²,Ka,r中位数为1607.0(883.5–4448.3)mGy。
  • 复杂PCI的KAP中位数为113.8(60.9–284.5)Gy-cm²,Ka,r中位数为2260.2(867.4–5311.9)mGy。
  • LH联合PCI的KAP中位数为91.7(6.0–426.0)Gy-cm²,Ka,r中位数为1589.3(100.2–7237.4)mGy;CRT起搏器的KAP中位数为51.1(7.0–175.9)Gy-cm²,Ka,r中位数为463.8(67.7–1695.9)mGy。

临床应用与阅片要点

  • 作者基于本中心现行实践提出六种心脏导管术的透视时间、KAP和介入参考点空气比释动能初始基准值,用于临床辐射剂量管理。
  • 作者认为这些基准数据可用于评估心脏导管室任何质量改进措施对辐射剂量优化的影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Cardiac catheterization procedures provide tremendous benefits to modern healthcare and the benefit derived by the patient should far outweigh the radiation risk associated with a properly optimized procedure. With increasing utilization of such procedures, there is growing concern regarding the magnitude and variations of dose to patients associated with procedure complexity and techniques parameters. Therefore, this study investigated radiation dose to patients from six cardiac catheterization procedures at our facility and suggest possible initial dose values for benchmark for patient radiation dose from these procedures. This initial benchmark data will be used for clinical radiation dose management which is essential for assessing the impact of any quality improvement initiatives in the cardiac catheterization laboratory.

METHODS: We retrospectively analyzed the dose parameters of 1000 patients who underwent various cardiac catheterization procedures: left heart catheterization (LH), percutaneous coronary intervention (PCI), complex PCI, LH with complex PCI, LH with PCI and cardiac resynchronization therapy (CRT) pacemaker in our cardiac catheterization laboratories. Patient's clinical radiation dose data [kerma-area-product (KAP) and air-kerma at the interventional reference point (Ka,r)] and technique parameters (fluoroscopy time, tube potential, current, pulse width and number of cine images) along with demographic information (age, height and weight) were collected from the hospital's RIS (Synapse), Sensis/Syngo Dynamics and Siemens Sensis Stats Manager electronic database. Statistical analysis was performed with the IBM SPSS Modeler v. 18.1 software.

RESULTS: The overall patient median age was 67.0 (range: 26.0-97.0) years and the median body mass index (BMI) was 28.8 (range: 15.9-61.7) kg/m2 . The median KAP for the LH, PCI, LH with complex PCI, complex PCI, LH with PCI and CRT-pacemaker procedures are 44.4 (4.1-203.2), 80.2 (18.9-208.5), 83.7 (48.0-246.1), 113.8 (60.9-284.5), 91.7 (6.0-426.0) and 51.1 (7.0-175.9) Gy-cm2 . The median Ka,r for the LH, PCI, LH with complex PCI, complex PCI, LH with PCI and CRT-pacemaker procedures are 701.0 (35.3-3794.0), 1384.7 (291.7-4021.8), 1607.0 (883.5-4448.3), 2260.2 (867.4-5311.9), 1589.3 (100.2-7237.4) and 463.8 (67.7-1695.9) mGy respectively.

CONCLUSION: We have analyzed patient radiation doses from six commonly used procedures in our cardiac catheterization laboratories and suggested possible initial values for benchmark from these procedures for the fluoroscopy time, KAP and air-kerma at the interventional reference point based on our current practices. Our data compare well with published values reported in the literature by investigators who have also studied patient doses and established benchmark dose levels for their facilities. Procedure-specific benchmark dose data for various groups of patients can provide the motivation for monitoring practices to promote improvements in patient radiation dose optimization in the cardiac catheterization laboratories.

ADVANCES IN KNOWLEDGE: We have investigated local patients' radiation doses and established benchmark radiation data which are essential for assessing the impact of any quality improvement initiatives for radiation dose optimization.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Osei B, Xu L, Johnston A, et al. Retrospective study of patients radiation dose during cardiac catheterization procedures. Br J Radiol. 2019. PMID: 31045448. doi:10.1259/bjr.20181021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。